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A B S T R A C T   
Flupyradifurone, a novel butenolide insecticide, selectively targets insect nicotinic acetylcholine receptors 
(nAChRs), comparable to structurally different insecticidal chemotypes such as neonicotinoids and sulfoximines. 
However, flupyradifurone was shown in acute toxicity tests to be several orders of magnitude less toxic to 
western honey bee (Apis mellifera L.) than many other insecticides targeting insect nAChRs. The underlying 
reasons for this difference in toxicity remains unknown and were investigated here. Pharmacokinetic studies 
after contact application of [14C]flupyradifurone to honey bees revealed slow uptake, with internalized com-
pound degraded into a few metabolites that are all practically non-toxic to honey bees in both oral and contact 
bioassays. Furthermore, receptor binding studies revealed a lack of high-affinity binding of these metabolites to 
honey bee nAChRs. Screening of a library of 27 heterologously expressed honey bee cytochrome P450 enzymes 
(P450s) identified three P450s involved in the detoxification of flupyradifurone: CYP6AQ1, CYP9Q2 and 
CYP9Q3. Transgenic Drosophila lines ectopically expressing CYP9Q2 and CYP9Q3 were significantly less sus-
ceptible to flupyradifurone when compared to control flies, confirming the importance of these P450s for flu-
pyradifurone metabolism in honey bees. Biochemical assays using the fluorescent probe substrate 7- 
benzyloxymethoxy-4-(trifluoromethyl)-coumarin (BOMFC) indicated a weak, non-competitive inhibition of 
BOMFC metabolism by flupyradifurone. In contrast, the azole fungicides prochloraz and propiconazole were 
strong nanomolar inhibitors of these flupyradifurone metabolizing P450s, explaining their highly synergistic 
effects in combination with flupyradifurone as demonstrated in acute laboratory contact toxicity tests of adult 
bees. Interestingly, the azole fungicide prothioconazole is only slightly synergistic in combination with flupyr-
adifurone – an observation supported by molecular P450 inhibition assays. Such molecular assays have value in 
the prediction of potential risks posed to bees by flupyradifurone mixture partners under applied conditions. 
Quantitative PCR confirmed the expression of the identified P450 genes in all honey bee life-stages, with highest 
expression levels observed in late larvae and adults, suggesting honey bees have the capacity to metabolize 
flupyradifurone across all life-stages. These findings provide a biochemical explanation for the low intrinsic 
toxicity of flupyradifurone to honey bees and offer a new, more holistic approach to support bee pollinator risk 
assessment by molecular means.   
* Correspondence to: Bayer AG, Crop Science Division, R&D, Building 6260, Alfred Nobel Str. 50, D40789 Monheim, Germany. 
E-mail address: ralf.nauen@bayer.com (R. Nauen).   
1 Joint first authors.  
2 Present address: idalab GmbH, 10785 Berlin, Germany.  
3 ORCID: 0000-0002-7525-8589. 
Contents lists available at ScienceDirect 
Ecotoxicology and Environmental Safety 
journal homepage: www.elsevier.com/locate/ecoenv 
https://doi.org/10.1016/j.ecoenv.2021.112247 
Received 18 January 2021; Received in revised form 1 April 2021; Accepted 8 April 2021   




(FPF) - known under the major brand name Sivanto® - is a novel 
butenolide insecticide developed for foliar, soil and seed treatment ap-
plications (Nauen et al., 2015). FPF was commercially introduced to the 
market in 2014 as an integrated pest management (IPM)-friendly tool 
(Bordini et al., 2021), and is registered for use in a wide variety of fruit 
and vegetable crops and defined broad acre crops. It targets some of the 
world́s most destructive sucking pests including aphids, psyllids, scales, 
leafhoppers, mealy bugs, and is particularly important for the control of 
whiteflies such as Bemisia tabaci, a vector of serious phytopathogenic 
viruses such as tomato yellow leaf curl virus and cucurbit yellow 
stunting disorder virus (Castle et al., 2017; Roditakis et al., 2017). FPF 
acts as a partial agonist of insect nicotinic acetylcholine receptors 
(nAChR) by reversible binding at the orthosteric site (Casida, 2018; 
Nauen et al., 2015). The electronegative butenolide pharmacophore of 
FPF is derived from the natural plant alkaloid stemofoline (Sakata et al., 
1978), and possesses a pronounced dipole moment (Fig. S1). This is 
important as electrostatic interactions are one of the key determinants of 
selective binding of such ligands to insect over vertebrate nAChRs 
(Casida and Durkin, 2013; Jeschke et al., 2013; Beck et al., 2015). 
Butenolides are sometimes confused with neonicotinoids, a different 
chemical class of insecticides that also act as selective agonists at the 
orthosteric site of insect nAChR, but originating from the synthetic 
nitromethylene heterocycle nithiazine (Jeschke and Nauen, 2008; 
Soloway et al., 1978). Some well-known insecticides such as imidaclo-
prid, thiamethoxam and clothianidin belong to the chemical class of 
neonicotinoids and carry an N-nitroguanidine pharmacophore (Casida, 
2018). They were launched in the early 1990s and have the greatest 
current market value of any insecticide class followed by the pyrethroids 
(Sparks et al., 2020). Neonicotinoids are known to be highly effective 
insecticides particularly when applied as a seed treatment (Jeschke 
et al., 2011), however, concerns were raised about possible environ-
mental and ecotoxicological risks (Goulson, 2013; Hladik et al., 2018; 
Pagano et al., 2020; Stara et al., 2020a, 2020b), and their potential role 
in recent bee pollinator declines (Blacquière et al., 2012; Godfray et al., 
2014; Lundin et al., 2015; Potts et al., 2016). In 2013 the European 
Commission (EC) suspended the use of imidacloprid, thiamethoxam and 
clothianidin seed treatments in bee-attractive crops such as oilseed rape 
(EU, 2013), followed by their complete ban for all outdoor uses in 2018, 
because according to the European Food Safety Authority (EFSA), these 
neonicotinoids pose a high risk to honey bees. While the N-nitro-
guanidine neonicotinoids are as intrinsically toxic to honey bees as to 
the insect pests they target (Iwasa et al., 2004), the N-cyanoimine 
neonicotinoid insecticides, such as thiacloprid and acetamiprid, are 
much less toxic to honey bees (Iwasa et al., 2004), and were exempt from 
the EU ban in 2018. Based on rather high acute LD50-values (> 11 
µg/bee) thiacloprid is classified as ‘practically non-toxic’ to honey bees 
(Schmuck, 2001; US EPA, 2014), and a recent assessment identified no 
critical issues of ecotoxicological concern (EFSA, 2019a). However, this 
compound was a candidate for substitution and its registration in EU-27 
was not renewed in April 2020. Like the N-cyanoimine neonicotinoids 
the butenolide FPF is several 100-fold less toxic to honey bees than 
imidacloprid, thiamethoxam and clothianidin (Casida, 2018; Nauen 
et al., 2015), suggesting that modulators of insect nAChRs are not 
inherently problematic to bees, just because they target a conserved 
receptor site in insects (Casida, 2018). Indeed, differential bee toxicity 
has been described for several classes of insecticides, independent of the 
target-site addressed by these insecticides (Hardstone and Scott, 2010; 
Reid et al., 2020). 
In order to explain the differential toxicity of insecticides addressing 
the same mode of action to bee pollinators, it is important to identify and 
understand the mechanisms underpinning selectivity. Honey bees as 
well as other insects recruit biochemical defense mechanisms based on 
metabolic enzymes to facilitate the detoxification of xenobiotic 
compounds such as plant secondary metabolites, and also pesticides 
(Johnson, 2015). Gene superfamilies expressing detoxification enzymes 
such as cytochrome P450-monooxygenases (P450s) are key to over-
coming or reducing the toxic effects mediated by foreign compounds 
(Gong and Diao, 2017; Panini et al., 2016; Rane et al., 2019). P450s, by 
far the most important group of detoxification enzymes, are involved in 
oxidative Phase I metabolism of a diverse range of xenobiotics, and are 
known to confer insecticide resistance (Dermauw et al., 2020; Feyer-
eisen, 2011). The detoxification gene inventory of honey bees, including 
P450s, is reduced compared to other insects (Claudianos et al., 2006), 
and it has been speculated that this deficit may render them more sen-
sitive to pesticides and lead to synergistic interactions among them 
(Berenbaum and Johnson, 2015). However, honey bees have been pre-
viously shown to exhibit marked tolerance to some pesticides such as 
tau-fluvalinate, a pyrethroid used in apiaries to control Varroa mites, an 
ectoparasite of increasing concern due to its involvement in global 
honey bee colony losses (Stokstad, 2019). It was found that the degra-
dation of tau-fluvalinate in honey bees is mediated by P450 enzymes and 
in particular the CYP9Q subfamily by forming metabolites susceptible to 
further cleavage by esterases (Johnson et al., 2006; Mao et al., 2011). 
Interestingly members of the same P450 subfamily were recently shown 
to be involved in the differential toxicity of neonicotinoid insecticides 
against honey bees. Manjon et al. (2018) demonstrated that CYP9Q3 
expressed in honey bee brain and Malpighian tubules, the insect 
equivalent of vertebrate kidneys, rapidly degraded thiacloprid but not 
imidacloprid. The authors functionally expressed all 27 honey bee P450 
enzymes of the CYP 3 clade in insect cells and provided several lines of 
evidence that CYP9Q3 is the molecular determinant of thiacloprid 
selectivity in honey bees. CYP9Q3 orthologs rapidly metabolizing thia-
cloprid were subsequently also identified and characterized in 
buff-tailed bumble bee, Bombus terrestris (Manjon et al., 2018; Troczka 
et al., 2019) and red mason bee, Osmia bicornis, a solitary bee species 
(Beadle et al., 2019). 
Honey bees are insects and adverse intrinsic effects upon contact to 
insecticides targeting a phylogenetically conserved and sensitive re-
ceptor site are therefore not surprising. As previously suggested, this 
innate risk needs to be mitigated by appropriate measures (Biddinger 
and Rajotte, 2015; Connolly, 2013; Hladik et al., 2018), helping farmers 
to protect their crops while avoiding harmful effect on off-target insects. 
The butenolide FPF was officially approved by the EU in 2015 (EU, 
2015), and is considered bee-safe according to standard regulatory 
pesticide risk assessment (EFSA, 2015). FPF has also been shown to be 
honey bee-safe under field conditions (EFSA, 2015; Campbell et al., 
2016), and an effective alternative solution for several highly destruc-
tive sucking pests formerly covered by neonicotinoid registrations 
(Nauen et al., 2015). FPF has a rather low acute contact toxicity to honey 
bees of > 100 µg/bee, and was shown to have a much lower impact on 
honey bee behavior at sublethal and field-relevant rates upon both acute 
and chronic exposure when compared to other modulators of nAChRs 
(Bell et al., 2020; Hesselbach et al., 2020; Hesselbach and Scheiner, 
2018, 2019; Tong et al., 2019; Wu et al., 2021). However, sublethal 
effects such as poor coordination and hyperactivity were recently 
described in honey bees when this compound was tested in combination 
with the fungicide propiconazole, suggesting that the inhibition of 
honey bee P450s by azole fungicides has the potential to synergize FPF 
toxicity (Tosi and Nieh, 2019). Indeed the flupyradifurone (Sivanto®) 
label in the U.S. already contains language prohibiting mixing of flu-
pyradifurone with azole fungicides during bloom period (https://www. 
cropscience.bayer.us/products/insecticides/sivanto/labels-msds). 
The objective of the present study was to uncover the mechanistic 
and molecular drivers that contribute to the low toxicity of FPF to honey 
bees. We used a honey bee toxicogenomics approach to study the 
pharmacokinetics, toxicodynamics and metabolic fate of FPF, in order to 
decipher and understand the molecular determinants of FPF selectivity. 
Our aim was to develop a detailed biochemical and physiological un-
derstanding of how FPF interacts with honey bees at the molecular level 
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and demonstrate the potential of this approach to complement existing 
methods for bee pollinator pesticide risk assessment. 
2. Materials and methods 
2.1. Chemicals 
[3H]imidacloprid (specific activity 1.406 GBq/µmol), flupyradifur-
one (FPF) (Fig. S1), [14C]-flupyradifurone (FPF) (label position fur-
anone-4-[14C], specific activity 4.24 MBq/mg), FPF-4-[(2,2- 
difluoroethyl)amino]-furanone (FPF-AF), FPF-acetic acid (FPF-AA), 
FPF-difluoroethanamine (FPF-DFEA) and FPF-hydroxy (FPF-OH) were 
of analytical grade and obtained in-house (Bayer AG, Monheim, Ger-
many). The fluorescent probe 7-benzyloxymethoxy-4-(trifluoromethyl)- 
coumarin (BOMFC; CAS 277309-33-8) was custom synthesized by 
Enamine Ltd. (Kiev, Ukraine) with a purity of 95%. Purchased technical 
pesticides used were of analytical grade and include: prothioconazole 
(CAS 178928-70-6, ≥ 99%, Sigma Aldrich PESTANAL® analytical 
standard), propiconazole (CAS 60207-90-1, ≥ 99%, Sigma Aldrich 
PESTANAL® analytical standard), prochloraz (CAS 67747-09-5, ≥ 98%, 
Sigma Aldrich PESTANAL® analytical standard) and imidacloprid (CAS 
138261-41-3, > 98%, Dr. Ehrenstorfer GmbH). HPLC gradient grade 
acetonitrile was purchased from Merck (Darmstadt, Germany). Unless 
otherwise mentioned all other chemicals were of analytical grade and 
obtained from Sigma-Aldrich (St. Louis, MO, USA). 
2.2. Honey bees 
Adult worker honey bees (Apis mellifera) used in the toxicity assays, 
pharmacokinetic and radioligand binding studies were of mixed age and 
collected from queen-right colonies located in Monheim, Germany (GPS: 
N 51.0750, E 6.8984), maintained pesticide-free and managed accord-
ing to standard beekeeping practice. The health status of the colonies 
was regularly checked by visual inspection. The colonies were not 
treated for Varroa mite control for at least three months prior to bee 
collection and testing. Honey bees used for gene expression analysis 
were collected from three different hives at the same location as 
mentioned above. Defined development stages were obtained by caging 
the queen and collecting larvae at 4, 6, 8, and 11 days post oviposition. 
Pupae were collected 18 days post oviposition. Adult bees were collected 
from frames containing brood (nurses), frames from the honey super 
(workers) and in front of the entrance (foragers). The samples were 
taken at two time points during the summer season and immediately 
snap frozen in liquid nitrogen and stored at − 80 ◦C until further use. 
2.3. Toxicity bioassays 
The acute oral and contact toxicity data of FPF and its respective 
metabolites against adult worker bees were assessed according to OECD 
guideline 213 (OECD, 1998a) and 214 (OECD, 1998b), and as recently 
published by the European Food Safety Authority (EFSA, 2015). We 
strictly followed the OECD guidelines without modification, i.e. all 
official criteria defined in the guidelines were met (particularly for oral 
assays), so studies were GLP compliant and meeting the EU regulatory 
requirements for plant protection product registration. Acute mixture 
contact toxicity assays were performed according to official OECD 
guideline 214 (OECD, 1998b) with slight adaptations to enable to test 
the hypothesis of synergism by fungicides. Briefly, bees were randomly 
collected from the honey super of different colonies in the morning and 
kept under test conditions (25 ◦C, 70% RH, complete darkness, in metal 
cages (L 8.5 x W 4.5 x H 6.5 cm (Fig. S2)) lined with filter paper) until 
treatment in the afternoon. Sucrose solution (50% w/v) was provided ad 
libitum. For fungicide/insecticide synergist bioassays worker bees were 
anaesthetized with CO2 and treated with 1 µL acetone containing 10 µg 
of the respective technical fungicide onto the dorsal thorax one hour 
prior to insecticide application. Afterwards, bees were again 
anaesthetized and FPF was applied in acetone at different concentra-
tions for dose-response analysis. Control bees were treated with acetone 
only. In synergist bioassays an additional control group was treated with 
the respective fungicide as a pre-treatment followed by acetone 1 h later. 
Applications were performed using a Hamilton syringe (Model 701N, 
Hamilton Company, Reno, NV, USA) Control mortality was < 10% in all 
cases and did not differ between 10 µg fungicide or acetone 
pre-treatment. Mortality was scored after 24 and 48 h. LD50-values and 
95% confidence intervals (95% CI) were calculated by probit analysis 
using PoloPlus 2.0 (LeOra Software, Petaluma, CA, USA). Synergistic 
ratios (SR) were calculated by dividing the LD50-value of the insecticide 
solo treatment by the LD50-value of the insecticide/fungicide combina-
tion treatment and was also performed by using the PoloPlus 2.0 soft-
ware. All bioassays were performed at least thrice with three replicates 
(n = 10 bees) per concentration. 
2.4. Flupyradifurone pharmacokinetics in vivo and metabolite analysis 
The pharmacokinetics and in vivo metabolism of FPF in worker bees 
was tracked by a [14C]-label at the furanone-4 position as recently 
described (Zaworra et al., 2019). Briefly: worker bees were collected 
from hives, randomly placed in metal cages in groups of five bees and 
kept in a darkened laboratory at room temperature for 24 h prior to 
treatment. Sucrose solution (500 g/L Apipuder (Südzucker, Mannheim, 
Germany)) was constantly provided ad libitum by syringes. After 24 h 
900 ng [14C]-FPF (approx. 227,000 dpm) dissolved in 2 µL acetone was 
applied onto the dorsal thorax of bees anesthetized with CO2. A group of 
control bees were treated with solvent only to check for solvent effects. 
Pharmacokinetic parameters were assessed 0, 2, 4 and 24 h after topical 
application in the treatment groups consisting of three replicates per 
time point. The subsequent sample preparation and metabolite analysis 
using LC-MS/MS was done exactly as described elsewhere (Zaworra 
et al., 2019). The electro-spray ionization MS spectra (ESI) for the 
extracted metabolites [14C]FPF, [14C]FPF-OH, [14C]FPF-AF and [14C] 
FPF-AA (Figs. S3–S6) were obtained with a Q Exactive mass spectrom-
eter (Thermo, San Jose, CA, U.S.A.) 24 h after FPF application. 
2.5. Receptor binding studies 
Nicotinic acetylcholine receptor (nAChR) binding affinity of FPF and 
its metabolites was measured by the displacement of [3H]-imidacloprid. 
Radioligand binding studies were performed using honey bee head 
membranes prepared from frozen (− 80 ◦C) honey bee heads following 
previously published protocols (Manjon et al., 2018). I50-values and 
corresponding 95% confidence limits (CL 95%) obtained from radio-
ligand displacement data were calculated using a four-parameter lo-
gistic non-linear fitting routine using GraphPad Prism software v8.3 
(GraphPad Software Inc., San Diego, CA, USA). 
2.6. Honey bee cytochrome P450 expression library 
Twenty-seven honey bee clade 3 cytochrome P450 proteins 
(Table S1) used in this study were obtained by functional recombinant 
expression in High Five insect cells co-infected with A. mellifera NADPH- 
dependent cytochrome P450 reductase (CPR) (Accession No.: 
XP_006569769.1) using the Bac-to-Bac baculovirus expression system 
(Thermo Fisher Scientific, Waltham, MA, USA) as recently described 
(Manjon et al., 2018; Nauen et al., 2021). Briefly: cells were harvested 
after 52 h, washed with Dulbecco’s phosphate-buffered saline, centri-
fuged and the cell pellet stored at − 80 ◦C until microsomal membrane 
preparation according to standard procedures (Janmohamed et al., 
2006), with minor changes. Briefly, cell pellets were homogenized for 
30 s in ice-cold 0.1 M potassium phosphate buffer, pH 7.6 containing 1 
mM EDTA, 1 mM DTT, 200 mM sucrose and one cOmplete™ EDTA-free 
Protease Inhibitor Cocktail tablet per 50 mL buffer, using a FastPrep-24 
5 G instrument (MP Biomedicals, Irvine, CA, USA) and centrifuged (10 
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min, 700 g, 4 ◦C). The supernatant was then again centrifuged at 100, 
000 g for 1 h at 4 ◦C and the pellet subsequently resuspended in 0.1 M 
potassium phosphate buffer (pH 7.6, 1 mM EDTA, 1 mM DTT, 5% 
glycerol) using a Dounce tissue grinder. Protein concentration was 
determined using Bradford reagent (Bio-Rad, Hercules, CA, USA) and 
bovine serum albumin (BSA) as a reference. 
2.7. Flupyradifurone metabolism by honey bee P450s and UPLC MS/MS 
analysis 
Functionally expressed honey bee P450s in isolated microsomes of 
High Five cells (2 mg mL− 1 protein) were incubated with 10 µM FPF for a 
quantitative parent compound depletion screening. Incubations were 
carried out in 0.1 M potassium phosphate buffer pH 7.6 containing an 
NADPH-regenerating system (Promega, 1.3 mM NADP+, 3.3 mM 
glucose-6-phosphate, 3.3 mM MgCl2, and 0.4 U/mL glucose-6- phos-
phate dehydrogenase) for 2 h at 30 ◦C in triplicate in 100 µL reaction 
volumes (40 µL microsomes, 10 µL 100 µM FPF and 50 µL buffer 
including NADPH regeneration system). Microsomes incubated without 
NADPH and cells infected with a mock virus served as controls. For 
Michaelis-Menten kinetics with recombinantly expressed CYP6AQ1, 
CYP9Q2 and CYP9Q3 (for GenBank accession numbers refer to Table S1) 
FPF was used in concentrations between 100 µM and 0.0317 µM 
employing the same assay conditions as described above with an incu-
bation time of 1 h. In all cases the reaction was stopped with the addition 
of 400 µL ice cold acetonitrile. The samples were then stored overnight 
at 4 ◦C for protein precipitation. Afterwards they were centrifuged at 
3200 g for 30 min at 4 ◦C and the supernatant subsequently analyzed by 
UPLC-MS/MS with slight modifications according to a previously pub-
lished protocol (Manjon et al., 2018). Briefly, for the chromatography on 
an Agilent 1290 Infinity II, a Waters Acquity HSS T3 column (2.1 × 50 
mm, 1.8 mm) with acetonitrile/water/1% formic acid as the eluent in 
gradient mode was employed. After positive electrospray ionization, ion 
transitions were recorded on a Sciex API6500 Triple Quad. FPF, FPF-OH, 
FPF-AF, FPF-AA and FPF-DFEA were measured in positive ion mode (ion 
transitions: FPF 289 > 126, FPF-OH 305 > 126, FPF-AF 164 > 146, 
FPF-AA 265 > 126, FPF-DFEA 207 > 126). The peak integrals were 
calibrated externally against a standard calibration curve. The linear 
range for the quantification of FPF, FPF-OH, FPF-AF, FPF-AA and 
FPF-DFEA was 0.1–200 ng/mL, 0.1–200 ng/mL, 2–100 ng/mL, 0.5–200 
ng/mL and 0.5–200 ng/mL, respectively. Samples were diluted prior to 
measurement if needed. Recovery rates of parent compound using 
microsomal fractions with recombinantly expressed P450s without 
NADPH were normally close to 100%. 
2.8. RNA isolation and RT-qPCR 
Total RNA of honey bee larvae was isolated from pools of five in-
dividuals. RNA from adults and pupae was isolated from individual 
animals and pooled afterwards. At least two pools per hive, sampling 
time and developmental stage were used for gene expression analysis. In 
total we analyzed more than 96 samples comprised of eight different life 
stages collected from three different hives at two time points (four-week 
interval). The snap-frozen samples were ground using a stainless-steel 
bead with four disruption cycles at 20 Hz for 30 s in a Mixer Mill MM 
300 (Retsch GmbH, Haan, Germany). RNA from first instar larvae was 
isolated using the PicoPure isolation kit (Thermo Fisher Scientific, 
Waltham, MA, USA) according to the manufacturer’s instructions. RNA 
from older larvae was isolated using the RNeasy Lipid Tissue Mini Kit 
(Qiagen, Hilden, Germany). An on-column RNase-Free DNase (Qiagen, 
Hilden, Germany) digest was included in both isolation procedures. 
Disrupted pupal and adult tissue was lysed using TRIzol™ Reagent 
(Invitrogen, Carlsbad, CA, USA), and crude RNA was isolated using 
phenol-chloroform extraction. The RNA was further purified from the 
aqueous phase via magnetic beads using the Agencourt RNAdvance 
Tissue Kit (Beckman Coulter, Brea, CA, USA), followed by a DNase I 
digest (Agilent Technologies, Santa Clara, CA, USA). RNA was quanti-
fied by spectrophotometry (NanoQuant Infinite 200, Tecan, 
Switzerland) and its integrity verified by an automated gel electropho-
resis system, according to CM-RNA and CL-RNA methods (QIAxcel RNA 
QC Kit v2.0, Qiagen, Hilden, Germany). For quantitative PCR (RT-qPCR) 
iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) was used for 
cDNA generation with 750 ng RNA used per reverse transcription re-
action. Real-time PCR was performed in triplicate using SsoAdvanced 
Universal SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) with 2.5 
ng cDNA and 0.25 µM of each primer (Table S2) in a total reaction 
volume of 10 µL using a CFX384™ Real-Time system (Bio-Rad), and 
non-template mixtures as negative controls. The PCR program was as 
follows: 95 ◦C for 30 s; 95 ◦C for 15 s; 64 ◦C for 15 s; 60 ◦C for 15 s, plate 
read; steps 2–5 were repeated 30 times followed by a final melt-curve 
post-PCR (ramping from 65 ◦C to 95 ◦C by 0.5 ◦C every 5 s) to check 
for non-specific amplification. The amplification efficiency was deter-
mined for each primer pair and inter-run controls were included in each 
run to minimize plate/run specific effects. For normalization two 
reference genes, polyubiquitin-A and tbp-association factor were selected. 
These have been validated in previous studies (Cornman et al., 2013; 
Lourenço et al., 2008) and showed good stability across life stages and 
tissues (M < 1; CV < 0.5). Gene expression analysis was performed using 
qbase + software version 3.1 (Biogazelle, Zwijnaarde, Belgium) (Hel-
lemans et al., 2007). 
2.9. Transgenic Drosophila bioassays and microsomal isolation 
Bioassays were conducted with Drosophila lines generated previ-
ously (Manjon et al., 2018, Table S3). Flies were reared in standard vials 
containing artificial diet (Jazz-Mix™ Drosophila Food, Thermo Fisher 
Scientific, Waltham, MA, USA). UAS-strains carrying the gene CYP9Q2 
or CYP9Q3 and a control strain generated with an empty plasmid were 
crossed with the Hsp70-GAL4 strain. Four to eight-day old female flies of 
the F1 generation were incubated at 37 ◦C three times for 30 min with 
1-hour intervals the day before starting the bioassay. Just prior to 
starting the bioassay, the flies were incubated once again. 
Bioassays were carried out in 12-well plates (Greiner Bio-One, 
Kremsmünster, Austria) with 2 mL artificial diet per well. FPF was dis-
solved and diluted in pure acetone. Each dilution was then further 
diluted 1:2 in ddH2O containing 0.1% Triton X-100. 50 µL of each 
concentration was transferred to a well (3 wells per concentration) and 
dispersed over the entire surface of the diet. Plates were left to dry 
completely before starting the bioassay. Ten flies were placed in each 
well. Full dose-response bioassays were repeated thrice. Mortality was 
scored after 48 h and 72 h. LD50 values were generated by probit anal-
ysis using PoloPlus 2.0 (LeOra Software, Petaluma, CA, USA). 
For microsomal isolation adult flies were snap frozen after the heat 
shock procedure was conducted as described above and stored at −
80 ◦C. Approximately 1 g of adult flies were homogenized for 30 s (4 
times) in 50 mL ice-cold 0.1 M potassium phosphate buffer (pH 7.6; 1 
mM EDTA; 1 mM DTT; 200 mM sucrose; one cOmplete™ EDTA-free 
Protease Inhibitor Cocktail tablet) using a FastPrep-24 5 G instrument 
(MP Biomedicals, Santa Ana, CA, USA). The homogenate was filtered 
through one layer of Miracloth (Merck Millipore, Burlington, MA, USA) 
and the microsomal fraction was obtained by differential centrifugation 
(10 min at 3000 g; 15 min at 10,000 g; 60 min at 100,000 g) at 4 ◦C. The 
resulting pellet was finally resuspended in 0.1 M potassium phosphate 
buffer (pH 7.6, 1 mM EDTA, 1 mM DTT, 5% glycerol) using a Dounce 
tissue grinder. Protein concentration was determined using Bradford 
reagent (Bio-Rad, Hercules, CA, USA) and bovine serum albumin (BSA) 
as a reference. Activity of microsomal fractions was confirmed against a 
selection of coumarin model substrates and FPF metabolism and quan-
tification of metabolites was performed exactly as described above for 
recombinant honey bee P450s (Section 2.7). 
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2.10. Honey bee P450 inhibition kinetics 
Michaelis-Menten kinetics for the recombinantly expressed honey 
bee P450s CYP9Q2, CYP9Q3 and CYP6AQ1 were conducted as previ-
ously described (Haas and Nauen, 2021) with slight modifications. 
Briefly, 7-benzyloxymethoxy-4-(trifluoromethyl)-coumarin (BOMFC) 
was used as a suitable fluorescent probe substrate for all three enzymes. 
The formation of 7-hydroxy-4-(trifluoromethyl)coumarin was linear 
with time and BOMFC concentration (data not shown). Final concen-
trations of microsomal preparations were 0.16 mg mL− 1 for CYP9Q2 and 
CYP9Q3 and 0.8 mg mL− 1 for CYP6AQ1. Fluorescence measurements 
were done using a microplate reader (Tecan Spark, Tecan Group Ltd., 
Männedorf, Switzerland) at an emission wavelength of λem 510 nm (20 
nm band width) while excited at λex 405 nm (20 nm band width). All 
other parameters were the same as described elsewhere (Haas and 
Nauen, 2021). 
For IC50 determinations a single BOMFC concentration close to its 
Km-value for the respective P450 enzyme was used, i.e. 6.5 µM, 15 µM 
and 20 µM for CYP9Q3, CYP9Q2 and CYP6AQ1, respectively (Fig. S7). 
The microsomal protein amount in 50 µL reaction volumes was 4 µg for 
measurements with CYP9Q2 and CYP9Q3, but 40 µg for CYP6AQ1. 
Azole fungicides were tested using a 5-fold dilution series ranging from 
50 to 0.0032 µM, whereas FPF and its metabolites were tested using a 5- 
fold dilution series ranging from 100 µM to 0.032 µM. All other pa-
rameters were the same as recently described (Haas and Nauen, 2021). 
2.11. Statistical analysis 
Significant differences (p < 0.05) in gene expression between life- 
stages was analyzed by one-way ANOVA with post hoc Tukeýs Honest 
Significant Difference (HSD) test. Further information on statistical data 
analysis is given in respective figure legends where appropriate. Enzy-
matic data obtained from substrate and/or inhibitor incubations with 
recombinantly expressed P450s were analyzed for competitive, non- 
competitive and mixed-type inhibition by non-linear regression 
assuming Michaelis-Menten kinetics using GraphPad Prism v8.3 
(GraphPad Software Inc., San Diego, CA, USA). All other experimental 
data were analyzed and visualized using GraphPad Prism v8.3 unless 
otherwise stated. 
3. Results 
3.1. Pharmacokinetics and metabolic fate of [14C]-FPF following contact 
exposure 
The pharmacokinetic behavior of [14C]-FPF in honey bees at 
different elapsed time intervals post-exposure was studied upon topical 
application of 900 ng a.i./bee, i.e. a dose 100-times lower than the 
contact LD50-value of FPF (> 100 µg/bee; Table 1). All bees survived the 
treatment and showed no symptoms of poisoning or behavioral abnor-
malities at any assessed time point. FPF penetrated the honey bee cuticle 
relatively slowly with 86.4 ± 3.75% and 76.2 ± 5.09% of the radiolabel 
recovered from the external wash 4 h and 24 h after application, 
respectively (Fig. 1). Twenty-four hours after application 12.4 ± 0.74% 
of the applied [14C]-FPF equivalents were extracted from bee tissue 
(internal), and 11.3 ± 4.95% collected as excreta, thus indicating 
clearance of almost 50% of the radiolabel within 24 h of cuticular uptake 
(Fig. 1). Qualitative HPLC ESI-MS analysis of honey bee tissue extracts 
revealed that the parent FPF dominates the recovered compounds, fol-
lowed by FPF-AF. Other metabolites identified were FPF-AA and FPF- 
OH, while some of the other smaller peaks could not be clearly identi-
fied (Fig. 2). 
3.2. Acute honey bee toxicity and nAChR binding of FPF metabolites 
The FPF metabolites FPF-OH, FPF-AF and FPF-AA identified in vivo 
were practically non-toxic to worker bees when tested in standard OECD 
acute contact and oral toxicity bioassays (Table 1). Even at the highest 
metabolite dose tested no symptoms of poisoning were observed. The 
resulting LD50-values were > 100 µg/bee and > 81.5 µg/bee after con-
tact and oral application, respectively. Considering the oral route of 
exposure, all metabolites are practically non-toxic when compared to 
FPF (LD50-value: 1.2 µg/bee), thus indicating an effective metabolic 
detoxification of FPF in honey bees. These bioassay findings are 
Table 1 
Inhibition of [3H]imidacloprid binding (I50) to honey bee head membrane nAChR preparations by the butenolide insecticide flupyradifurone and its metabolites 
compared with the neonicotinoid imidacloprid and one of its main metabolites, 5-hydroxy-imidacloprid (IMD-OH).     
nAChR binding studies LD50 (µg a.i./bee) 
Chemical class Compound I50 [nM] CL 95% Ratioa Contact Oral 
Butenolide Flupyradifurone (FPF) 7.6 5.8–9.9 – > 100 1.2 
Neonicotinoid Imidacloprid (IMD) 1.2 0.93–1.6 – 0.0251 0.0037 
Butenolide FPF-OH 1700 430–6800 224 > 100 > 105  
FPF-amino-furanone (FPF-AF) > 10,000 – > 1300 > 100 > 81.5  
FPF-acetic acid (FPF-AA) > 10,000 – > 1300 > 100 > 90  
FPF-difluoroethanamine (FPF-DFEA) > 10,000 – > 1300 > 100 nd 
Neonicotinoid IMD-OH 24 15–37 20 – 0.159 
Acute honey bee toxicity data were taken from Nauen et al. (2001), Nauen et al. (2015) and EFSA (2015), except for FPF-AA and FPF-DFEA (this study). 
a Binding affinity relative to the parent compound 



















Fig. 1. Uptake and distribution of [14C]-FPF-equivalents expressed as percent 
recovered radioactivity at different elapsed time intervals after topical appli-
cation of honey bee adults with [14C]-FPF (900 ng). Data are mean val-
ues ± SEM (n = 3). (For interpretation of the references to colour in this figure 
legend, the reader is referred to the web version of this article.). 
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supported by the lack of competitive high-affinity binding of any of the 
tested metabolites to [3H]imidacloprid sensitive nAChRs in honey bee 
head membrane preparations when compared to FPF, which showed 
nanomolar affinity in radioligand binding studies (Table 1). This is in 
strong contrast to one of the major metabolites of the neonicotinoid 
imidacloprid after contact application, IMD-OH (Zaworra et al., 2019), 
which shows high-affinity binding to honey bee nAChRs in the nano-
molar range (I50 24 nM) and an oral LD50-value of 0.159 µg/bee 
(Table 1). FPF-OH, the hydroxylated butenolide variant, and minor 
metabolite detected in vivo (Fig. 2), binds with much lower affinity 
(71-fold) to honey bee nAChRs and is practically non-toxic 
(> 105 µg/bee) in acute oral bioassays. The major FPF metabolite 
detected in our pharmacokinetic study, FPF-AF, did not bind to nAChRs 
at concentrations as high as 10,000 nM (Table 1). Finally, our data 
revealed a significant 6-fold lower binding affinity of FPF to honey bee 
nAChR preparations than the neonicotinoid insecticide imidacloprid 
(I50-values of 7.6 and 1.2 nM, respectively; Table 1). 
3.3. Cytochrome P450-mediated degradation of FPF 
In order to investigate the oxidative metabolic fate of FPF at the 
molecular level we recombinantly expressed 27 different CYP3 clade 
honey bee P450 enzymes individually in High Five cells and examined 





























Fig. 2. HPLC radiohistogram of a sample extracted from honey bees topically treated with 900 ng [14C]-FPF 24 h prior to extraction for qualitative metabolite 
profiling using ESI-MS. Reference standards allowed the identification of three metabolites: (1) FPF-(difluoroethyl)amino-furanone (FPF-AF), (2) FPF-acetic acid 

































































































Fig. 3. (A) Flupyradifurone (FPF) depletion by 27 recombinantly expressed cytochrome P450s of the honey bee CYP3 clade measured by UPLC-MS/MS analysis and 
(B) quantity of metabolites detected after the incubation of FPF with recombinantly expressed honey bee CYP9Q3 (top), CYP9Q2 (center) and CYP6AQ1 (bottom). 
Data are mean values ± SD (n = 3). FPF-(difluoroethyl)amino-furanone (FPF-AF), FPF-5́hydroxy (FPF-OH), FPF-difluoroethanamine (FPF-DFEA) and FPF-acetic acid 
(FPF-AA). (C) Proposed scheme of oxidative metabolic fate of FPF mediated by honey bee cytochrome P450s. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.). 
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tested, and mock cell microsomal preparations, did not metabolize FPF. 
However, a significant depletion of FPF was observed after incubation of 
FPF with functionally expressed CYP9Q2, CYP9Q3 and CYP6AQ1 
(Fig. 3A), identifying them as strong candidate enzymes driving the 
oxidative metabolism of FPF in vivo. A more detailed quantitative UPLC- 
MS/MS analysis revealed that the hydroxylation of the furanone moiety 
- resulting in FPF-OH - is catalyzed by all three P450s at varying levels 
and follows Michaelis-Menten kinetics, with highest Vmax values ob-
tained for CYP6AQ1 (Fig. S8). However, the cleavage of the 6-chloro- 
pyridinylmethylamine bridge forming FPF-AF (and its counterpart 6- 
chloro-2-picolyl alcohol) is in particular mediated by CYP9Q2 
(Fig. 3B). We identified a third metabolite, FPF-DFEA, most likely 
resulting from the oxidative degradation of the FPF(-OH) furanone 
moiety catalyzed by CYP9Q2 and CYP9Q3 (Fig. 3B and C). The metab-
olite FPF-DFEA was not detected during the in vivo pharmacokinetic 
study with radiolabeled FPF, because the applied FPF was labeled at the 
[furanone-4-14C] position (Fig. 2). We hypothesize that FPF-AA 
(detected in vivo) and its unstable oxidized derivative FPF-AA-2-oxo, 
respectively, are potential intermediates resulting in FPF-DFEA 
(Fig. 3C). 
3.4. Enzyme kinetics, biochemical characterization and validation of FPF- 
metabolizing P450s 
We identified BOMFC as an appropriate probe substrate to measure 
the activity of the FPF-metabolizing and recombinantly expressed P450s 
CYP9Q2, CYP9Q3 and CYP6AQ1. The P450 catalyzed formation of the 
fluorescent product, 7-hydroxy-4-(trifluoromethyl)coumarin (HC), can 
be easily followed facilitating high-throughput rapid enzyme kinetic 
measurements. CYP9Q3-mediated fluorescent product formation is 
inhibited by increasing concentrations of FPF (Fig. 4A), and Michaelis- 
Menten kinetics revealed significantly decreased Vmax values and un-
changed Km values, indicating non-competitive inhibition of HC for-
mation by FPF (Table S4). Similar results were obtained for CYP9Q2 and 
CYP6AQ1 and are summarized in Table S4. Full dose response analysis 
revealed a rather weak inhibition of BOMFC metabolism by FPF 
(Fig. 4B) as well as FPF-OH (Fig. 4C) for all three P450 enzymes, as 
demonstrated by I50-values of > 10 µM (Table S5). Based on the fluo-
rescence assays with BOMFC we noticed that FPF-OH showed the 
highest affinity to CYP9Q3 (I50 20.9 µM), followed by CYP9Q2 (I50 69.2) 
– whereas CYP6AQ1 is hardly affected by FPF-OH (I50 > 300 µM), which 
is in contrast to its much more pronounced affinity to FPF (I50 17.0 µM) 
(Table S5). These enzyme kinetic data strongly support the analytical 
results on the metabolic detoxification of FPF we obtained for the in-
dividual P450s (Fig. 3C). Particularly, the interaction of FPF-OH with 
the different P450s shown in Fig. 4C correlates with the extent of FPF- 
DFEA formation by recombinantly expressed CYP9Q3 and CYP9Q2 
when directly incubated with FPF-OH (Fig. 4D), thus supporting the 
proposed oxidative metabolic fate of FPF shown in Fig. 3C. Recombi-
nantly expressed CYP6AQ1 did not form FPF-DFEA, a finding strongly 
supported by the lack of binding of FPF-OH to CYP6AQ1 (Fig. 4C and 
Table S5). 
In order to provide a further line of evidence underpinning the 
importance of the identified P450s for the oxidative metabolism of FPF, 
we employed two lines of transgenic Drosophila ectopically expressing 
the honey bee genes CYP9Q2 and CYP9Q3, respectively. No such 
transgenic line was available for CYP6AQ1. Transgenic flies expressing 
CYP9Q2 or CYP9Q3 under the control of a HSP70 promoter were 






























































































































Fig. 4. (A) Steady-state kinetics of 7-hydroxy-4-(trifluoromethyl)coumarin (HC) formation by CYP9Q3 using BOMFC as a substrate in the presence of flupyradifurone 
(FPF). (B) Effect on P450-mediated BOMFC metabolism by increasing concentrations of FPF and (C) FPF-OH; data are mean values ± SD (n = 4). (D) Formation of 
FPF-difluoroethanamine (FPF-DFEA) by honey bee P450s incubated with FPF-OH (n = 3). (E) Efficacy of FPF against transgenic Drosophila strains ectopically 
expressing CYP9Q2 and CYP9Q3, respectively, in comparison to a control strain (Empty); data are mean values ± SEM (n = 3). (F) Quantification of FPF-OH and 
FPF-DFEA after incubation of FPF with microsomal preparations of transgenic flies expressing honey bee CYP9Q2 and CYP9Q3 in comparison to control flies; data are 
mean values ± SD (n = 3). LOQ = limit of quantitation. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of 
this article.). 
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significantly less sensitive to FPF compared to a control strain lacking 
the transgenes (Fig. 4E). The LD50-value of FPF against flies expressing 
CYP9Q3 and CYP9Q2 was 65.7 µg/cm2 (CI95% 55.3–81.6) and 45.3 µg/ 
cm2 (CI95% 39.8–51.7), respectively, when compared to a control strain 
(LD50 26.5 µg/cm2; CI95% 20.1–36.0) (Table S6). This finding demon-
strates the potential of CYP9Q2 and CYP9Q3 to confer FPF tolerance in 
vivo. Based on the calculated LD50-values and non-overlapping confi-
dence intervals (95%) CYP9Q3 expressing flies were significantly less 
sensitive to FPF than CYP9Q2 expressing flies. This is consistent with the 
findings obtained for the recombinantly expressed enzymes in the 
biochemical and analytical assays described above. Furthermore, we 
incubated FPF with microsomal fractions prepared from transgenic 
Drosophila and subsequently analyzed them by UPLC-MS/MS for the 
presence of FPF metabolites. We detected the formation of FPF-OH and 
FPF-DFEA in microsomes from flies expressing CYP9Q3, whereas the 
metabolite levels in microsomal preparations from all other lines were 
below the limit of quantification (Fig. 4F). The detection of both FPF-OH 
and FPF-DFEA in microsomal preparations from CYP9Q3 expressing 
flies is in line with our findings obtained from FPF incubations with 
recombinantly expressed CYP9Q3 (Fig. 3B). 
3.5. P450 gene expression profiling across honey bee life stages 
We used RT-qPCR to determine the level of expression of the iden-
tified FPF-degrading P450s at eight different time points across honey 
bee life-stages, covering early to late larval instars, early and late pupal 
stages after brood cell capping, as well as adults divided into nurse, 
worker (in hive) and foragers, collected at the hive entrance. The highest 
expression levels for all three P450 genes was observed in late larvae and 
adults, suggesting a high potential to detoxify FPF in these life stages. 
CYP6AQ1 and CYP9Q2 were expressed 1000-fold and 100-fold higher in 
adults compared to first instar larvae respectively (Fig. 5). Overall, the 
expression level followed a similar pattern for the three P450 genes 
implicated in FPF-metabolizing, i.e. showing rather high expression 
levels before brood cell capping, a significant decline during pupation 
and a marked, highly significant increase after eclosion (Fig. 5). Based 
on the rather low P450 transcript levels at the early larval stages, i.e. four 
and six days after oviposition, we assume that these stages have the 
lowest capacity to detoxify FPF. In contrast, adults, that collect and 
process pollen as food for larval consumption, have the greatest capacity 
to metabolize FPF based on the high expression levels of CYP6AQ1, 
CYP9Q2 and CYP9Q3 in this life stage. 
3.6. P450 inhibition by azole fungicides and FPF synergism 
Having deciphered the honey bee P450s involved in the detoxifica-
tion of FPF we tested their sensitivity to three common azole fungicides 
in order to predict their potential to synergize FPF acute honey bee 
toxicity under laboratory conditions. Such a mechanistic approach at the 
molecular level can be used to rapidly uncover possible toxicity risks of 
applying FPF as mixtures with these fungicides. We utilized the fluo-
rescent probe kinetic assay described above and measured the inhibition 
of P450-mediated BOMFC metabolism by prochloraz, propiconazole and 
prothioconazole (Fig. 6A). Prochloraz strongly inhibited CYP9Q3, 
CYP9Q2 and CYP6AQ1 activity exhibiting I50-values of 13 nM, 29 nM 
and 6.8 nM, respectively (Table S7). Propiconazole also inhibited 
CYP9Q3 and CYP9Q2 in the nanomolar range exhibiting I50-values of 
72 nM and 160 nM, respectively. It was a less effective inhibitor of 
CYP6AQ1, as demonstrated by an I50-value of 1100 nM. In contrast to 
prochloraz and propiconazole, prothioconazole was a very weak in-
hibitor of CYP9Q3 and CYP9Q2, showing I50-values of 39,000 nM and 
19,000 nM, respectively. However, it was somewhat more active against 
CYP6AQ1 (I50 3700 nM), but still significantly less effective when 
compared to the other azole fungicides (Table S7). 
Honey bee contact toxicity bioassays revealed a strong synergism of 
FPF acute toxicity by propiconazole and prochloraz, but not 
prothioconazole (Fig. 6B). FPF was synergized by > 243-fold and > 112- 
fold when pre-treated with prochloraz and propiconazole, respectively 
(Table S8), whereas, the synergistic ratio observed in combination with 
prothioconazole was much lower (>1.15). Thus, the capacity of these 
fungicides to synergize the toxicity of FPF in in vivo is entirely consistent 
with the ability of these compounds to inhibit key FPF-metabolizing 
P450 enzymes. 
4. Discussion 
FPF belongs to the new class of butenolide insecticides that selec-
tively target insect nAChRs, with a similar mode of action as other 
commercial competitive modulators acting on nAChRs such as neon-
icotinoids and sulfoximines (Nauen et al., 2015; Casida, 2018). Our 







































































































































Fig. 5. Relative expression measured by quantitative PCR of honey bee P450 
genes involved in the oxidative detoxification of flupyradifurone. Significant 
differences (p < 0.05) in expression between life-stages are denoted by different 
letters above bars as determined by one-way ANOVA with post hoc Tukey HSD. 
(For interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.). 
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radioligand binding studies confirm this mode of action, although FPF 
showed a slightly, but significantly lower binding affinity to honey bee 
nAChR preparations than the neonicotinoid insecticide imidacloprid. 
However, this finding is likely explained by the chemical differences 
between these insecticides, with FPF characterized by its novel bute-
nolide pharmacophore, as previously demonstrated using chem-
informatics (Jeschke et al., 2015; Nauen et al., 2015). This is further 
supported by homology modeling and docking approaches at the level of 
calculated electron densities, which revealed slight differences between 
nAChR modulators in their binding topology at the orthosteric site of 
nAChRs (Beck et al., 2015). However, despite its nanomolar receptor 
binding affinity, FPF is significantly less acutely toxic to honey bees 
compared to most neonicotinoid insecticides and sulfoximines (Iwasa 
et al., 2004; EFSA, 2015; EFSA, 2019b). In order to uncover the un-
derlying physiological and biochemical principles explaining the low 
acute honey bee toxicity of FPF, we combined pharmacokinetic and 
toxicogenomic approaches as a complement to standard regulatory bee 
pollinator pesticide risk assessment (López-Osorio and Wurm, 2020). 
Indeed, such approaches have already been successfully employed to 
decipher the molecular determinants of neonicotinoid selectivity in 
different bee pollinator species (Manjon et al., 2018; Beadle et al., 2019; 
Zaworra et al., 2019), and to understand the biochemical mechanisms of 
pesticide synergism in honey bees (Haas and Nauen, 2021). 
Our pharmacokinetic studies revealed a slow uptake of topically 
applied [14C]FPF through the honey bee cuticle over 24 h (23.7%). This 
is less than that recorded for the neonicotinoids thiacloprid (38%) and 
imidacloprid (60%) over the same time interval (Zaworra et al., 2019). 
Additionally, half of the amount of [14C]FPF equivalents taken up by 
honey bees were excreted within 24 h, suggesting a rapid clearance of 
parent compound as well as radiolabeled FPF metabolites. Zaworra et al. 
(2019) showed in an almost identical experimental set-up that [14C] 
imidacloprid equivalents accumulated in honey bees and were only 
slowly excreted. However, the authors showed that imidacloprid treated 
bees exhibited neurotoxic symptoms of poisoning, most likely slowing 
down functional metabolism and excretion, as reported in earlier studies 
(Suchail et al., 2004). Based on the pharmacokinetic results obtained 
here, we suggest that limited penetration and rapid clearance are factors 
contributing to the classification of FPF as “practically non-toxic” (U.S. 
EPA, 2014) upon contact application in acute tier I honey bee toxicity 
assays (LD50 >100 µg/bee). It is worth mentioning that cuticle-applied 
thiacloprid showed a pharmacokinetic behavior comparable to FPF 
(Zaworra et al., 2019), but its affinity to honey bee nAChRs is 7-fold 
higher compared to FPF (Manjon et al., 2018). This suggests a phar-
macokinetically driven toxicodynamic component is involved in the 
differential acute toxicity between FPF and neonicotinoid insecticides. 
The acute oral toxicity of FPF (LD50 1.2 µg/bee) is > 80-fold higher 
than its acute contact toxicity, suggesting a quicker absorption and 
distribution via this exposure route. However, in contrast to the neon-
icotinoid imidacloprid, the oral toxicity of the butenolide FPF is several 
hundred-fold lower (Table 1). This is not explained by differences in 
their physicochemical properties or their affinity to honey bee nAChRs. 
HPLC analysis of homogenized honey bee tissue samples taken from our 
pharmacokinetic experiment with [14C]FPF suggest that the low acute 
oral toxicity of FPF is most likely based on its in vivo metabolic fate. This 
results in the generation of practically non-toxic FPF metabolites that 
lack high affinity nAChR binding properties. We clearly identified three 
[14C]-labeled metabolites: FPF-AF, FPF-AA and FPF-OH, most likely 
generated by, (1) cleavage of the 6-chloro-pyridinylmethylamine 
bridge, (2) oxidative degradation of the butenolide moiety and (3) hy-
droxylation of the butenolide moiety, respectively. These empirically 
identified sites of oxidative attack match those computationally pre-
dicted by local reactivity descriptors using Fukui functions (Beck, 2005; 
Fig. S1). FPF-OH formed the smallest fraction of the metabolites iden-
tified in vivo. Previous pharmacokinetic studies with the neonicotinoids 
imidacloprid and thiacloprid detected hydroxy-imidacloprid and 
hydroxy-thiacloprid as major metabolites, respectively (Suchail et al., 
2004; Zaworra et al., 2019). Of these hydroxylated imidacloprid has 
been shown to bind strongly to insect nAChRs and to be highly toxic to 
honey bees (Table 1), suggesting that its formation as a major metabolite 
facilitates toxicity (Nauen et al., 2001; Suchail et al., 2001, 2004). In 
contrast, FPF-OH binds only weakly to honey bee nAChR preparations, 
and, as demonstrated here, binding is too weak to result in measurable 
acute oral and contact toxicity. As we used furanone-4-[14C] radio-
labeled FPF we failed to detect any expected (major) non-labeled me-
tabolites resulting from its degradation pathway, such as 6-chloropicolyl 
alcohol and its further oxidized derivative 6-chloronicotinic acid, how-
ever, both these metabolites are practically non-toxic to honey bees as 
they lack the attached butenolide pharmacophore (EFSA, 2015). 
The pharmacokinetic data presented here strongly suggested oxida-
tive degradation as the key pathway for the metabolic fate of FPF. 
Therefore, we employed a recently constructed P450 library of the 
honey bee CYP 3 clade to identify potential candidate genes mediating 
FPF metabolism (Manjon et al., 2018). We incubated FPF in vitro with 27 
different honey bee P450 enzymes recombinantly expressed in insect 
cells and identified three candidate P450s involved in the depletion of 
FPF, namely CYP9Q2, CYP9Q3 and CYP6AQ1. Both CYP9Q2 and 
CYP9Q3 are involved in the formation of FPF-AF (and 6-chloropicolyl 
alcohol) as well as FPF-OH, whereas CYP6AQ1 selectively hydroxyl-
ates FPF. We also demonstrated that CYP9Q2 and CYP9Q3, but not 
CYP6AQ1, are involved in consecutive oxidative reactions leading to 
FPF-DFEA, a metabolite lacking the butenolide pharmacophore, which 
is therefore inactive. This metabolite is possibly formed via FPF-AA as an 
intermediate product, which we have not detected in vitro (see Fig. 3). 
On the other hand, we did not detect FPD-DFEA (but FPF-AA) in our in 
vivo pharmacokinetic experiment, given that we applied [fur-
anone-4-14C]-FPF and not [6-chloro-pyridinylmethyl-14C]-FPF. 
CYP9Q2 and CYP9Q3 have been previously described as the mo-
lecular determinants of neonicotinoid selectivity in honey bees, i.e. 
explaining the practically non-toxic behavior of N-cyanoimine neon-
icotinoids such as thiacloprid and acetamiprid by mediating 
Fig. 6. (A) Inhibition of recombinantly expressed CYP9Q3, CYP9Q2 and CYP6AQ1 by three azole fungicides using BOMFC as a substrate. Data are mean values ± SD 
(n = 4). (B) Dose-response relationship and synergism of flupyradifurone (FPF) when topically applied to honey bees either alone or pre-treated with the azole 
fungicides propiconazole (PRP), prothioconazole (PRT) and prochloraz (PRC). Data are mean values ± SEM (n = 3–4). (For interpretation of the references to colour 
in this figure legend, the reader is referred to the web version of this article.). 
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hydroxylation and N-demethylation, respectively (Manjon et al., 2018). 
The same P450 subfamily was already shown to be involved in tau--
fluvalinate, coumaphos and quercetin metabolism in honey bees (Mao 
et al., 2011). Furthermore, it was demonstrated that the expression of 
CYP9Q2 and CYP9Q3 in the honey bee brain is induced upon exposure 
to insecticidal organophosphates (Christen and Fent, 2017). Taken 
together, these studies provide a growing body of evidence that P450s of 
the CYP9Q subfamily play a crucial role in the detoxification of diverse 
chemical classes of xenobiotics in honey bees, including several in-
secticides. Indeed, this claim is further supported by studies demon-
strating that functionally expressed CYP9Q orthologs from bumblebees 
(Bombus terrestris), i.e. CYP9Q4, CYP9Q5 and CYP9Q6 (Manjon et al., 
2018; Troczka et al., 2019), and red mason bees (Osmia bicornis), i.e. 
CYP9BU1 and CYP9BU2 (Beadle et al., 2019), metabolized N-cyanoi-
mine neonicotinoids. It remains to be shown if these orthologs of honey 
bee CYP9Q genes also mediate FPF metabolism. However, recently 
published FPF acute contact toxicity LD50-values are comparatively low 
(LD50 > 11 µg/bee) against both B. terrestris and O. bicornis, possibly 
indicating an evolutionary conserved role for these CYP9Q orthologs in 
xenobiotic detoxification and thus FPF selectivity across several bee 
species. This conclusion is further supported by a recent study linking 
the increased sensitivity of the alfalfa leafcutter bee, Megachile rotun-
data, towards the above-mentioned compounds (including FPF) to the 
lack of CYP9Q orthologs in its genome (Hayward et al., 2019). 
The constitutive expression of honey bee CYP9Q genes has been 
investigated extensively, revealing that it is highest in detoxification- 
relevant tissues and life stages. For example, CYP9Q transcripts have 
been found at high levels in the brain and Malpighian tubules (Manjon 
et al., 2018; Vannette et al., 2015), and shown to be elevated in 
mandibular and hypopharyngeal glands, as well as in antennae and legs 
of honey bee foragers when compared to nurse bees (Mao et al., 2015; 
Vannette et al., 2015). Our study revealed constitutive expression of 
CYP9Q2, CYP9Q3 and CYP6AQ1 across developmental stages with 
highest levels in those stages primarily exposed to xenobiotics, e.g. 
adults, but also late larvae. The observed expression profile, particularly 
in motile stages, likely mirrors a general protective role of these P450s in 
xenobiotic defense in honey bees. The lower expression in (early) larval 
stages might suggest that larvae are more susceptible to flupyradifurone 
than adults, but this is not supported by in-vivo data where a comparable 
toxicity between adults and larvae is observed (EFSA, 2015). However, 
we still think it is an interesting topic for future research. Little is known 
about CYP6AQ1 and its role in xenobiotic detoxification, however, a 
recent study described its transcriptional regulation after exposure to a 
pyrethroid insecticide (Wieczorek et al., 2020). Interestingly, significant 
up- and/or down-regulation of P450 gene expression after FPF exposure 
was not found in honey bee larvae (Kablau et al., 2020) or adults (Wu 
et al., 2021), suggesting a minor, if any, role in honey bee P450 induc-
tion by FPF. However, P450 induction and possible consequences on the 
detoxification of the respective inducing agent needs to be interpreted 
with care. For example, none of the P450s induced by honey bee 
exposure to thiacloprid metabolized thiacloprid when functionally 
expressed in E. coli (Alptekin et al., 2016). This finding demonstrates the 
importance of functionally validating the detoxification role of genes 
upregulated upon exposure to chemicals such as insecticides. Recently, a 
fluorescent probe-based assay of honey bee P450 enzymes has been 
described that allows the rapid identification of P450-insecticide in-
teractions (Haas and Nauen, 2021). In the present study, steady-state 
kinetics of 7-hydroxy-4-(trifluoromethyl)coumarin formation by 
CYP9Q3, CYP9Q2 and CYP6AQ1 using BOMFC as a substrate in the 
presence of FPF unambiguously confirmed its binding to the catalytic 
site of these enzymes. Similar assays have been used for many years in 
the pharmaceutical industry to screen for adverse effects of drugs on 
human P450 enzymes (Fowler and Zhang, 2008; Kosaka et al., 2017), 
and it has been recently proposed that similar molecular approaches can 
complement current bee pollinator pesticide risk assessment 
(López-Osorio and Wurm, 2020). Here, transgenic Drosophila ectopically 
expressing honey bee CYP9Q2 and CYP9Q3 (McLeman et al., 2020) 
were employed to provide an additional line of evidence for the 
importance of these enzymes in FPF selectivity. As shown earlier for 
thiacloprid (Manjon et al., 2018), these transgenic flies were also 
significantly more tolerant to FPF than wildtype flies, underpinning the 
crucial role for CYP9Q2 and CYP9Q3 for the observed FPF tolerance in 
honey bees. We also confirmed FPF-OH and FPF-DFEA as the main 
metabolites generated by microsomal preparations from transgenic flies 
expressing CYP9Q3. Interestingly, no FPF metabolites were detected in 
microsomal preparations of control flies that lack a transgene, demon-
strating that the microsomal P450 gene inventory of Drosophila, even if 
more diverse compared to honey bees (Berenbaum and Johnson, 2015), 
lacks the capacity to detoxify FPF. 
Finally, we were able to show that the identified honey bee P450s 
mediating FPF metabolism are strongly inhibited by commonly used 
fungicides such as propiconazole and prochloraz, and to a much lesser 
extent by prothioconazole. This finding explains at the molecular level 
the synergistic effects recently described when FPF was co-applied with 
the azole fungicide propiconazole (Tosi and Nieh, 2019). The synergistic 
effect demonstrated by the authors is most likely based on the inhibition 
of the individual P450s identified here that are directly involved in the 
metabolic fate of FPF. Similar synergistic effects, leading to increased 
honey bee toxicity, were demonstrated with thiacloprid/prochloraz 
mixtures (Wernecke et al., 2019). In this case it was shown, using the 
recently proposed molecular pesticide risk assessment approach, that 
the observed synergism is driven by the inhibition of CYP9Q3 (Haas and 
Nauen, 2021). Interestingly, intrinsic synergistic effects of prothioco-
nazole are very weak in vivo (Table S8; supported by rather low P450 
inhibition in vitro) and may not even qualify as synergism according to 
the definitions that have been used to constitute a synergistic effect 
(Cedergreen, 2014; Belden and Brain, 2018; Carnesecchi et al., 2019). 
Use restrictions are in place regarding tank mixtures of flupyradifurone 
with azole fungicides during bloom and the obtained data demonstrate 
the importance of pesticide applicators adhering to that guidance to 
mitigate the risk of synergistic interaction. Our results, however, raise 
the question if all azole fungicides can be considered equal when it 
comes to their inhibitory potential towards essential cytochrome P450s. 
Synergistic interactions between pesticides in bees have been known 
for a long time (Pilling and Jepson, 1993; Pilling et al., 1995; Johnson 
et al., 2006; Iwasa et al., 2004), but are now an issue of growing regu-
latory concern (Johnson et al., 2013; Robinson et al., 2017; Sgolastra 
et al., 2017; Carnesecchi et al., 2019). However, as demonstrated here 
for FPF, if the molecular basis driving synergistic effects for a given 
insecticide is known, biochemical assays can provide a useful comple-
ment to existing risk assessment approaches by allowing a better un-
derstanding of the mechanistic basis of potential adverse interactions 
(López-Osorio and Wurm, 2020; Haas and Nauen, 2021). It is, however, 
important to acknowledge that higher tier studies under field-applied 
conditions at realistic exposure scenarios remain important to eluci-
date the impact of potential harmful interactions identified in the lab-
oratory (Schmuck et al., 2003; Thompson et al., 2014). 
In conclusion, our pharmacokinetic and toxicogenomic approach has 
provided new insights into the molecular mechanisms contributing to 
the honey bee safety profile of the butenolide insecticide FPF. We pro-
pose that the data gathered using such a mechanistic pesticide risk 
assessment approach has strong potential to significantly complement 
that generated in whole-organism studies as part of existing regulatory 
requirements. 
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